+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Middle East Cell Therapy Raw Materials Market Size, Share & Trends Analysis Report by Product (Media, Sera, Cell Culture Supplements), by End Use (Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs), by Country, and Segment Forecasts, 2025-2033- Product Image
Middle East Cell Therapy Raw Materials Market Size, Share & Trends Analysis Report by Product (Media, Sera, Cell Culture Supplements), by End Use (Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs), by Country, and Segment Forecasts, 2025-2033- Product Image
New

Middle East Cell Therapy Raw Materials Market Size, Share & Trends Analysis Report by Product (Media, Sera, Cell Culture Supplements), by End Use (Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs), by Country, and Segment Forecasts, 2025-2033

  • PDF Icon

    Report

  • 90 Pages
  • August 2025
  • Region: Middle East
  • Grand View Research
  • ID: 6168216
Description Jump to:
The Middle East cell therapy raw materials market size was estimated at USD 39.2 million in 2024 and is expected to reach USD 169.8 million by 2033, expanding at a CAGR of 17.8% from 2025 to 2033. This growth is driven by increasing investments in regenerative medicine, the rising prevalence of chronic and rare diseases, and expanding research initiatives across countries such as the UAE, Saudi Arabia, and Qatar. Moreover, government-backed funding programs and collaborations between regional research institutes and international biotech firms are accelerating the adoption of advanced cell therapy products.

Rising Prevalence of Chronic & Rare Diseases

The growing burden of chronic and rare diseases in the Middle East is a key factor driving the demand for raw materials for cell therapy. Conditions such as cancer, diabetes, cardiovascular disorders, and genetic abnormalities are increasing in prevalence due to aging populations, urbanization, and changing lifestyle patterns. Many of these illnesses have limited treatment options with conventional medicine, pushing healthcare systems to adopt advanced therapeutic approaches such as regenerative medicine and cell-based interventions. As these therapies require consistent and high-quality inputs, there is a rising need for GMP-grade raw materials, including cell culture media, growth factors, cytokines, and cryopreservation agents, to ensure their efficacy, safety, and scalability of treatments.

Moreover, the shift towards personalized medicine in the region is amplifying this demand. As a result, healthcare providers increasingly focus on treatments tailored to individual patient profiles, necessitating specialized raw materials compatible with unique genetic and biological characteristics. The Middle East's growing network of research institutions, hospitals, and biotech firms is intensifying efforts in cell therapy development, creating a sustained requirement for reliable, regulatory-compliant raw materials. This trend is expected to gain momentum as governments invest in healthcare modernization and cross-border collaborations with global biotech companies expand access to cutting-edge therapeutic solutions.

Middle East Cell Therapy Raw Materials Market Report Segmentation

This report forecasts revenue growth at regional and country levels and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. The analyst has segmented the Middle East cell therapy raw materials market based on product, end use, and country:

Product Outlook (Revenue, USD Million, 2021-2033)

  • Media
  • Sera
  • Cell Culture Supplements
  • Antibodies
  • Reagents & Buffers
  • Others

End Use Outlook (Revenue, USD Million, 2021-2033)

  • Biopharmaceutical & Pharmaceutical Companies
  • CROs & CMOs
  • Others

Country Outlook (Revenue, USD Million, 2021-2033)

  • Middle East
  • Saudi Arabia
  • UAE
  • Kuwait
  • Qatar
  • Oman
  • Rest of Middle East

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the industry across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segmental and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Product
1.2.2. End Use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Primary Research
1.6. Information or Data Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Validation
1.8. Market Model
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. List of Abbreviations
1.11. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising prevalence of chronic and rare diseases
3.2.1.2. Government-led healthcare investments
3.2.2. Market Restraint Analysis
3.2.2.1. High cost associated with the production and procurement of raw materials
3.2.2.2. Stringent regulations associated with cell therapies
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
Chapter 4. Product Business Analysis
4.1. Product Segment Dashboard
4.2. Middle East Cell Therapy Raw Materials Market: Product Movement Analysis
4.3. Middle East Cell Therapy Raw Materials Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
4.4. Media
4.4.1. Media Market, 2021-2033 (USD Million)
4.5. Sera
4.5.1. Sera Market, 2021-2033 (USD Million)
4.6. Cell Culture Supplements
4.6.1. Cell Culture Supplements Market, 2021-2033 (USD Million)
4.7. Antibodies
4.7.1. Antibodies Market, 2021-2033 (USD Million)
4.8. Reagents & Buffers
4.8.1. Reagents & Buffers Market, 2021-2033 (USD Million)
4.9. Others
4.9.1. Others Market, 2021-2033 (USD Million)
Chapter 5. End-use Business Analysis
5.1. End use Segment Dashboard
5.2. Middle East Cell Therapy Raw Materials Market: End-use Movement Analysis
5.3. Biopharmaceutical & Pharmaceutical Companies
5.3.1. Biopharmaceutical & Pharmaceutical Companies Market, 2021-2033 (USD Million)
5.4. CROs & CMOs
5.4.1. CROs & CMOs Market, 2021-2033 (USD Million)
5.5. Others
5.5.1. Others Market, 2021-2033 (USD Million)
Chapter 6. Middle East Cell Therapy Raw Materials Market: Regional Estimates & Trend Analysis
6.1. Country Market Share Analysis, 2024 & 2033
6.2. Country Market Dashboard
6.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
6.4. Middle East
6.4.1. Saudi Arabia
6.4.1.1. Key country dynamics
6.4.1.2. Competitive scenario
6.4.1.3. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
6.4.2. UAE
6.4.2.1. Key country dynamics
6.4.2.2. Competitive scenario
6.4.2.3. UAE market estimates and forecasts 2021 to 2033 (USD Million)
6.4.3. Kuwait
6.4.3.1. Key country dynamics
6.4.3.2. Competitive scenario
6.4.3.3. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
6.4.4. Qatar
6.4.4.1. Key country dynamics
6.4.4.2. Competitive scenario
6.4.4.3. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
6.4.5. Oman
6.4.5.1. Key country dynamics
6.4.5.2. Competitive scenario
6.4.5.3. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
6.4.6. Rest of Middle East
6.4.6.1. Key country dynamics
6.4.6.2. Competitive scenario
6.4.6.3. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 7. Competitive Landscape
7.1. Company Categorization
7.2. Strategy Mapping
7.3. Company Position Analysis, 2024
7.4. Company Profiles
7.4.1. Thermo Fisher Scientific Inc.
7.4.1.1. Overview
7.4.1.2. Financial Performance
7.4.1.3. Product Benchmarking
7.4.1.4. Strategic Initiatives
7.4.2. Merck KGaA
7.4.2.1. Overview
7.4.2.2. Financial Performance
7.4.2.3. Product Benchmarking
7.4.2.4. Strategic Initiatives
7.4.3. Actylis.
7.4.3.1. Overview
7.4.3.2. Product Benchmarking
7.4.3.3. Strategic Initiatives
7.4.4. ACROBiosystems
7.4.4.1. Overview
7.4.4.2. Product Benchmarking
7.4.4.3. Strategic Initiatives
7.4.5. STEMCELL Technologies
7.4.5.1. Overview
7.4.5.2. Product Benchmarking
7.4.5.3. Strategic Initiatives
7.4.6. Grifols, S.a.
7.4.6.1. Overview
7.4.6.2. Financial Performance
7.4.6.3. Product Benchmarking
7.4.6.4. Strategic Initiatives
7.4.7. Charles River Laboratories
7.4.7.1. Overview
7.4.7.2. Financial Performance
7.4.7.3. Product Benchmarking
7.4.7.4. Strategic Initiatives
7.4.8. RoosterBio, Inc.
7.4.8.1. Overview
7.4.8.2. Product Benchmarking
7.4.8.3. Strategic Initiatives
7.4.9. PromoCell GmbH
7.4.9.1. Overview
7.4.9.2. Product Benchmarking
7.4.9.3. Strategic Initiatives
7.4.10. Danaher
7.4.10.1. Overview
7.4.10.2. Financial Performance
7.4.10.3. Product Benchmarking
7.4.10.4. Strategic Initiatives
7.4.11. Sartorius Stedim Biotech
7.4.11.1. Overview
7.4.11.2. Financial Performance
7.4.11.3. Product Benchmarking
7.4.11.4. Strategic Initiatives
List of Tables
Table 1 List of abbreviation
Table 2 Middle East & Africa cell therapy raw materials market, by country, 2021-2033 (USD Million)
Table 3 Middle East & Africa cell therapy raw materials market, by product, 2021-2033 (USD Million)
Table 4 Middle East & Africa cell therapy raw materials market, by end-use, 2021-2033 (USD Million)
Table 5 Saudi Arabia cell therapy raw materials market, by product, 2021-2033 (USD Million)
Table 6 Saudi Arabia cell therapy raw materials market, by end-use, 2021-2033 (USD Million)
Table 7 UAE cell therapy raw materials market, by product, 2021-2033 (USD Million)
Table 8 UAE cell therapy raw materials market, by end-use, 2021-2033 (USD Million)
Table 9 Kuwait cell therapy raw materials market, by product, 2021-2033 (USD Million)
Table 10 Kuwait cell therapy raw materials market, by end-use, 2021-2033 (USD Million)
Table 11 Qatar cell therapy raw materials market, by product, 2021-2033 (USD Million)
Table 12 Qatar cell therapy raw materials market, by end-use, 2021-2033 (USD Million)
Table 13 Oman cell therapy raw materials market, by product, 2021-2033 (USD Million)
Table 14 Oman cell therapy raw materials market, by end-use, 2021-2033 (USD Million)
Table 15 Rest of Middle East cell therapy raw materials market, by product, 2021-2033 (USD Million)
Table 16 Rest of Middle East cell therapy raw materials market, by end-use, 2021-2033 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Middle East Cell therapy raw materials market segmentation
Figure 3 Data analysis models
Figure 4 Market formulation and validation
Figure 5 Data validating & publishing
Figure 6 Market research process
Figure 7 Information procurement
Figure 8 Primary research
Figure 9 Value-chain-based sizing & forecasting
Figure 10 QFD modelling for market share assessment
Figure 11 Market formulation & validation
Figure 12 Commodity flow analysis
Figure 13 Market snapshot
Figure 14 Segment snapshot
Figure 15 Segment snapshot
Figure 16 Competitive landscape snapshot
Figure 17 Market trends & outlook
Figure 18 Porter’s five force analysis
Figure 19 SWOT analysis, by factor (Political, Economic, Social, Technological, and Legal)
Figure 20 Middle East Cell therapy raw materials market: product outlook key takeaways
Figure 21 Middle East Cell therapy raw materials market: product movement analysis
Figure 22 Media market, 2021-2033 (USD Million)
Figure 23 Sera market, 2021-2033 (USD Million)
Figure 24 Cell culture supplements market, 2021-2033 (USD Million)
Figure 25 Antibodies market, 2021-2033 (USD Million)
Figure 26 Reagents & buffers market, 2021-2033 (USD Million)
Figure 27 Others market, 2021-2033 (USD Million)
Figure 28 Cell therapy raw materials market: end-use outlook key takeaways
Figure 29 Cell therapy raw materials market: end-use movement analysis
Figure 30 Biopharmaceutical & pharmaceutical companies market, 2021-2033 (USD Million)
Figure 31 CROs & CMOs supplements market, 2021-2033 (USD Million)
Figure 32 Others supplement market, 2021-2033 (USD Million)
Figure 33 Middle East Cell therapy raw materials market revenue, by country, 2022 & 2033 (USD Million)
Figure 34 Country marketplace outlook, 2024 & 2033 (USD Million)
Figure 35 Country marketplace: Key takeaways
Figure 36 Key country dynamics
Figure 37 Saudi Arabia cell therapy raw materials market estimates and forecasts, 2021-2033 (USD Million)
Figure 38 Key country dynamics
Figure 39 UAE cell therapy raw materials market estimates and forecasts, 2021-2033 (USD Million)
Figure 40 Key country dynamics
Figure 41 Kuwait cell therapy raw materials market estimates and forecasts, 2021-2033 (USD Million)
Figure 42 Key country dynamics
Figure 43 Qatar cell therapy raw materials market estimates and forecasts, 2021-2033 (USD Million)
Figure 44 Key country dynamics
Figure 45 Oman cell therapy raw materials market estimates and forecasts, 2021-2033 (USD Million)
Figure 46 Key country dynamics
Figure 47 Rest of Middle East cell therapy raw materials market estimates and forecasts, 2021-2033 (USD Million)
Figure 48 Market participant categorization
Figure 49 Strategic framework

Companies Mentioned

The major companies profiled in this Middle East Cell Therapy Raw Materials market report include:
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher
  • Sartorius Stedim Biotech
  • Actylis.
  • ACROBiosystems
  • STEMCELL Technologies.
  • Grifols, S.A.
  • Charles River Laboratories
  • RoosterBio, Inc.
  • PromoCell GmbH

Table Information

Report AttributeDetails
No. of Pages90
PublishedAugust 2025
Forecast Period2024 - 2033
Estimated Market Value ( USD ) in 2024 $ 39.2 Million
Forecasted Market Value ( USD ) by 2033 $ 169.8 Million
Compound Annual Growth Rate17.8%
Regions CoveredMiddle East
No. of Companies Mentioned12

Related Topics

Related Reports

U.S. Cell Therapy Raw Materials Market Size, Share & Trends Analysis Report by Product (Media, Sera, Antibodies, Reagents & Buffers), by End-use (Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs), by Region, and Segment Forecasts, 2025-2033 - Product Image

U.S. Cell Therapy Raw Materials Market Size, Share & Trends Analysis Report by Product (Media, Sera, Antibodies, Reagents & Buffers), by End-use (Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs), by Region, and Segment Forecasts, 2025-2033

  • Report
  • 90 Pages
  • United States
From
Cell And Gene Therapy Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III), By Indication (Oncology, Cardiology, CNS, Musculoskeletal, Infectious Diseases), By Region, And Segment Forecasts, 2025 - 2033 - Product Image

Cell And Gene Therapy Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III), By Indication (Oncology, Cardiology, CNS, Musculoskeletal, Infectious Diseases), By Region, And Segment Forecasts, 2025 - 2033

  • Report
  • 150 Pages
  • Global
From
Cell & Gene Therapy Contract Research Organizations Market Size, Share & Trends Analysis Report By Type (Drug Discovery, Preclinical, Clinical), By Service (Regulatory Strategy, Clinical Monitoring), By Indication, By Modality, By Region, And Segment Forecasts, 2025 - 2033 - Product Image

Cell & Gene Therapy Contract Research Organizations Market Size, Share & Trends Analysis Report By Type (Drug Discovery, Preclinical, Clinical), By Service (Regulatory Strategy, Clinical Monitoring), By Indication, By Modality, By Region, And Segment Forecasts, 2025 - 2033

  • Report
  • 150 Pages
  • Global
From
Middle East Plasmid DNA Manufacturing Market Size, Share & Trends Analysis Report by Disease (Cancer, Infectious Diseases), by Grade (R&D, GMP), by Application, by Development Phase, by Country, and Segment Forecasts, 2025-2033 - Product Image

Middle East Plasmid DNA Manufacturing Market Size, Share & Trends Analysis Report by Disease (Cancer, Infectious Diseases), by Grade (R&D, GMP), by Application, by Development Phase, by Country, and Segment Forecasts, 2025-2033

  • Report
  • 150 Pages
  • Middle East
From
Middle East Genome Editing Market Size, Share & Trends Analysis Report by Technology (CRISPR/Cas9, ZFN), by Delivery Method (Ex Vivo. in Vivo), by Application, by Mode (Contract, in-house), by End Use, by Country, and Segment Forecasts, 2025-2033 - Product Image

Middle East Genome Editing Market Size, Share & Trends Analysis Report by Technology (CRISPR/Cas9, ZFN), by Delivery Method (Ex Vivo. in Vivo), by Application, by Mode (Contract, in-house), by End Use, by Country, and Segment Forecasts, 2025-2033

  • Report
  • 90 Pages
  • Middle East
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.